Hypoxia and Medicine

Home > Chronic Hypoxia Information > Chronic Hypoxia News

Chronic Hypoxia News

  • Deaths | PUBLIC RECORDS | May 19 to June 13 Sunday, June 26, 2011 @ 12:42AMDeaths | PUBLIC RECORDS | May 19 to June 13
  • Enhancing medication safety with computerized alerts Friday, February 18, 2011 @ 12:20PMMedication errors are responsible for a large number of adverse drug events in patients each year, and the use of medication-related abbreviations accounts for nearly five percent of these errors. Strategies to reduce the use of problematic abbreviations -- which can lead to overdosage or incorrect or missed medications because of staff misinterpretation -- have largely focused on education ...
  • AngioDynamics adds low-profile, mini models to Smart Port CT family of power-injectable ports Monday, July 12, 2010 @ 6:24AMAngioDynamics announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex® port technology - to include low-profile and mini models for repeated treatments such as chemotherapy and for use with computed tomography (CT).
  • Aushon BioSystems introduces new Human multiplex biomarker panels Friday, July 2, 2010 @ 4:22AMAushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
  • Earth Talk Wednesday, June 23, 2010 @ 12:20AMDear EarthTalk: Is it true that the BP oil leak is much more of an environmental threat than previous spills from tankers, and if so why?
  • Health: Drink drops of oxygen Monday, June 21, 2010 @ 7:15PMReplenish oxygen supply to your body with oxygen therapy. MEENA SREENIVASAN finds out more HUMAN beings cannot survive without oxygen.
  • Novartis' Afinitor decreases size of SEGAs associated with tuberous sclerosis Monday, June 7, 2010 @ 7:11AMNovartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology ...
  • Gulf oil spill could widen, worsen 'dead zone' (w/ Video) Monday, June 7, 2010 @ 7:07AM(PhysOrg.com) -- While an out-of-control gusher deep in the Gulf of Mexico fouls beaches and chokes marshland habitat, another threat could be growing below the oil-slicked surface.
  • JCI online early table of contents: May 3, 2010 Monday, May 3, 2010 @ 4:33PMThis release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, May 3rd, 2010, in the JCI: The protein tPA provides protection for nerve cells; Conquering a severe complication of celiac disease; How statins modulate immune function; One, two: counting the genes causing deafblindness in individual patients; Immune system going ...
  • Gregg Semenza Named Canada Gairdner International Awardee Wednesday, April 14, 2010 @ 10:52AMGregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Pediatrics, director of the vascular program at the Johns Hopkins Institute for Cell Engineering and a member of the McKusick-Nathans Institute of Genetic Medicine, is one of seven recipients of the 2010 Canada Gairdner Awards. Canada's only international science prizes, they are among the world's most prestigious medical research ...
  • Gregg Semenza Named Canada Gairdner International Awardee Friday, April 9, 2010 @ 9:01PMGregg Semenza, M.D., Ph.D., director of the vascular program at the Johns Hopkins Institute for Cell Engineering and a member of the McKusick-Nathans Institute of Genetic Medicine, is one of seven recipients of the 2010 Canada Gairdner Awards. Canada's only international science prizes, they are among the world's most prestigious medical research awards. The awards, each of which comes with a ...
  • Link Between Low Oxygen Levels In Body And Cancer-Aiding Protein Tuesday, March 9, 2010 @ 12:23PMResearch could help treatments for retinoblastoma and breast cancerWhat began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma.Dolores Takemoto, a Kansas State University professor of biochemistry who was researching protein kinase C gamma in the lens of the human eye, found her work ...
  • Low oxygen levels in body linked to cancer-aiding protein Tuesday, March 9, 2010 @ 11:23AMA professor of biochemistry who was researching protein kinase C gamma in the lens of the human eye found her work taking a fascinating turn when she discovered a correlation between the protein Coonexin46 and hypoxia -- a deficiency of oxygen which kills normal tissue cells. The researcher believes the findings will lead to serious advancements in treating retinoblastoma, a cancer that forms in ...
  • K-State professor finds link between low oxygen levels in body and cancer-aiding protein Tuesday, March 9, 2010 @ 10:35AM( Kansas State University ) Dolores Takemoto, a K-State professor of biochemistry who was researching protein kinase C gamma in the lens of the human eye, found her work taking a fascinating turn when she discovered a correlation between the protein Coonexin46 and hypoxia -- a deficiency of oxygen which kills normal tissue cells. Takemoto believes the findings will lead to serious advancements ...
  • KSU Professor Discovers Link Between Oxygen, Cancer Protein Tuesday, March 9, 2010 @ 10:05AMA Kansas State University biochemistry professor discovered a link between low oxygen levels in the body and a cancer-aiding protein. The discovery could help treatments for retinoblastoma and breast cancer.
  • In rural areas, more women falling into health care gap Tuesday, December 15, 2009 @ 10:15AMFor Americans living in rural areas, obtaining and maintaining health care can be challenging. Aside from common barriers, including shortages of care providers and facilities, older women face additional challenges, according to Kay Libbus, a public health researcher at the University of Missouri. Libbus says that women ages 50-65 living in rural areas are at-risk for inadequate health care ...
  • Zevalin® (Ibritumomab Tiuxetan) Demonstrated Activity in Several Investigational Phase 2 Trials Presented at the 51st ... Friday, December 11, 2009 @ 6:00AMIRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN was presented at the 51st Annual Meeting of the American Society of Hematology , which was held December 5-8, 2009 at the Ernest N.
  • Severe COPD Linked to Mental Decline Thursday, November 5, 2009 @ 11:31AMDoctors need to recognize challenges these patients face, researchers say.
  • MHA announces endorsement relationship between AHR, VISTA Staffing Solutions and On Assignment Monday, October 5, 2009 @ 5:08AMThe Maine Hospital Association (MHA) has announced an exclusive endorsement relationship between their wholly owned entity, Associated Health Resources, Inc. (AHR), VISTA Staffing Solutions, Inc., and On Assignment, Inc.
  • Infant and toddler health Saturday, September 12, 2009 @ 2:54AMCar seat safety isn't child's play. Understand 10 common mistakes parents often make when installing and using car safety seats.
  • Infant and toddler health Saturday, September 12, 2009 @ 2:54AMCar seat safety isn't child's play. Understand 10 common mistakes parents often make when installing and using car safety seats.
  • Discovery Of Specific Mutations Involved In Evolutionary Adaptation To Different Environments Wednesday, August 12, 2009 @ 5:13AMBiologists have long known how adaptive evolution works. New mutations arise within a population and those that confer some benefits to the organism increase in frequency and eventually become fixed in the population. A significant challenge for evolutionary biologists, however, has been to identify the specific mutations that are responsible for adaptive change.
  • Team Discovers Specific Mutations Involved In Evolutionary Adaptation To Different Environments Tuesday, August 11, 2009 @ 9:11AMBiologists have long known how adaptive evolution works.
  • Biologists identify the molecular basis of high-altitude adaptation in mice Monday, August 10, 2009 @ 4:33PM(PhysOrg.com) -- Biologists have long known how adaptive evolution works. New mutations arise within a population and those that confer some benefits to the organism increase in frequency and eventually become fixed in the population.
  • CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union Sunday, June 28, 2009 @ 5:17AMMerck & Co., Inc. (Whitehouse Station, N.J., U.S.A.), which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommending restricted first line use of 'Januvia' (sitagliptin) for the treatment of type 2 diabetes.
  • Simple drug treatment may prevent nicotine-induced SIDS Wednesday, June 3, 2009 @ 1:37PM(PhysOrg.com) -- A new study has identified a specific class of pharmaceutical drugs that could be effective in treating babies vulnerable to Sudden Infant Death Syndrome (SIDS), because their mothers smoked during pregnancy.
  • New Nice Guideline For Type 2 Diabetes Recognises Benefits From Newer Agents For Blood Glucose Control Friday, May 29, 2009 @ 10:20AMMerck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the UK, which recommends considering a range of newer therapy options, including 'Januvia' (sitagliptin).